The Core Legal Strategy Against Opioid Companies May Be Faltering by BY JAN HOFFMAN


Two recent rulings rejected the “public nuisance” argument being used in thousands of cases against the industry, with more trials and settlement talks underway.

Published: November 11, 2021 at 11:00AM

from NYT Health https://ift.tt/3D8DqMT